ArticlePDF Available

Epicardial adipocyte hypertrophy: Association with M1-polarization and toll-like receptor pathways in coronary artery disease patients

Authors:

Abstract and Figures

Background and aims: In coronary artery disease (CAD) epicardial adipose tissue (EAT) shows an elevated inflammatory infiltrate. Toll-like receptors (TLRs) are important mediators of adipose tissue inflammation and they are able to recognize endogenous products released by damaged cells. Because adipocyte death may be driven by hypertrophy, our aim was to investigate in CAD and non-CAD patients the association between EAT adipocyte size, macrophage infiltration/polarization and TLR-2 and TLR-4 expression. Methods and results: EAT biopsies were collected from CAD and non-CAD patients. The adipocyte size was determined by morphometric analysis. Microarray technology was used for gene expression analysis; macrophage phenotype and TLRs expression were analyzed by immunofluorescence and immunohistochemical techniques. Inflammatory mediator levels were determined by immunoassays. EAT adipocytes were larger in CAD than non-CAD patients and do not express perilipin A, a marker of lipid droplet integrity. In CAD, EAT is more infiltrated by CD68-positive cells which are polarized toward an M1 state (CD11c positive) and presents an increased pro-inflammatory profile. Both TLR-2 and TLR-4 expression is higher in EAT from CAD and observed on all the CD68-positive cells. Conclusions: Our findings suggested that EAT hypertrophy in CAD promotes adipocyte degeneration and drives local inflammation through increased infiltration of macrophages which are mainly polarized towards an M1 state and express both TLR-2 and TLR-4.
Content may be subject to copyright.
Epicardial adipocyte hypertrophy: Association with M1-polarization
and toll-like receptor pathways in coronary artery disease patients
E. Vianello
a,
*
,1
, E. Dozio
a,1
, F. Arnaboldi
a
, M.G. Marazzi
a
, C. Martinelli
a
, J. Lamont
b
,
L. Tacchini
a
, A. Sigrüner
c
, G. Schmitz
c
, M.M. Corsi Romanelli
a,d
a
Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy
b
Randox Laboratories LTD, R&D, Crumlin-Antrim, Belfast, Northern Ireland, UK
c
Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany
d
SMEL-1 Clinical Pathology, I.R.C.C.S. Policlinico San Donato, Milan, Italy
Received 18 March 2015; received in revised form 2 November 2015; accepted 7 December 2015
Available online ---
KEYWORDS
Epicardial adipose
tissue (EAT);
Coronary artery
disease (CAD);
Macrophages
inltration;
Toll-like receptors
(TLRs)
Abstract Background and aims: In coronary artery disease (CAD) epicardial adipose tissue (EAT)
shows an elevated inammatory inltrate. Toll-like receptors (TLRs) are important mediators of
adipose tissu e inammation and they are able to recognize endogenous products released by
damaged cells. Because adipocyte death may be driven by hypertrophy, our aim was to investi-
gate in CAD and non-CAD patients the association between EAT adipocyte size, macrophage inl-
tration/polarization and TLR-2 and TLR-4 expression.
Methods and results: EAT biopsies were collected from CAD and non-CAD patients. The adipocyte
size was determined by morphometric analysis. Microarray technology was used for gene
expression analysis; macrophage phenotype and TLRs expression were analyzed by immunou-
orescence and immunohistochemical techniques. Inammatory mediator levels were deter-
mined by immunoassays.
EAT adipocytes were larger in CAD than non-CAD patients and do not express perilipin A, a
marke r of lipid droplet integrity. In CAD, EAT is more in ltrated by CD68-posit ive cells which
are polarized toward an M1 state (CD11c positive) and presents an increased pro-
inammatory prole. Both TLR-2 and TLR-4 expression is higher in EAT from CAD and observed
on all the CD68-positive cells.
Conclusions: Our ndings suggested that EAT hypertrophy in CAD promotes adipocyte degener-
ation and drives local inammation through increased inltration of macrophages which are
mainly polarized towards an M1 state and express both TLR-2 and TLR-4.
ª 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the
Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Feder-
ico II University. Published by Elsevier B.V. All rights reserved.
Introduction
Coronary artery disease (CAD) is a clinical condition
characterized by stenosis of coronary vessels due to
atherosclerotic plaque formation. Recently, CAD onset and
progression has been related to epicardial adipose tissue
(EAT), a visceral fat depot surrounding the heart and
sharing with myocardium the same microcirculation [1].
* Corresponding author. Department of Biomedical Sciences for Health, Università degli Studi di Milano, Via Luigi Mangiagalli 31, 20133 Milan,
Italy. Tel.: þ39 02 50315342; fax: þ39 02 50315338.
E-mail address: elena.vianello@unimi.it (E. Vianello).
1
These author equally contribute in this article.
Please cite this article in press as: Vianello E, et al., Epicardial adipocyte hypertrophy: Association with M1-polarization and toll-like
receptor pathways in coronary artery disease patients, Nutrition, Metabolism & Cardiovascular Diseases (2016), http://dx.doi.org/
10.1016/j.numecd.2015.12.005
http://dx.doi.org/10.1016/j.numecd.2015.12.005
0939-4753/ª 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of
Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Nutrition, Metabolism & Cardiovascular Diseases (2016) xx,1e8
Available online at www.sciencedirect.com
Nutrition, Metabolism & Cardiovascular Diseases
journal homepage: www.elsevier.com/locate/nmcd
With increasing thickness, EAT is able to locally produce
reactive oxygen species, cytokines and chemokines which
may create a local toxic and pro-inammatory environ-
ment [2e5]. In particular, visceral obese patients display
an increased EAT thickness and the tissue is mostly inl-
trated by macrophages which may amplify the local pro-
inammatory response by producing itself additional
mediators [6,7].
Immunohistochemical identication of macrophages is
usually performed with antibody against CD68 antigen.
These cells may be further characterized according to their
polarization state as pro-inammatory CD11c-positive
macrophages, known as M1 [8,9], and anti-inammatory
CD206-positive macrophages, known as M2 [10]. The po-
larization process depends on different local stimuli
[11,12].
Recently, the presence of stressed or dying adipocytes,
releasing different cellular components, like residual lipid
droplets, has been suggested as an additional stimulus
inducing macrophage inltration and M1 polarization,
probably through the activation of toll-like receptors
(TLRs) which play a primary role in the innate immune
response [13,14]. Although TLRs are mainly known for
their ability to recognize different pathogen-associated
molecular patterns, recently it has been shown that they
can also recognize endogenous molecules, such as heat
shock proteins or cell debris [15], called damage-
associated molecular patterns (DAMPs) [16].
In the eld of CAD, recent studies suggested that
macrophage EAT inltration is also one of the main causes
of the chronic inammatory state associated with the
disease [17,18]. Moreover, it has been reported that TLR-2
and TLR-4 are the main TLR isoforms involved in athero-
sclerosis and their expression is up-regulated in circulating
monocytes [19e21].
Currently, less is known about the mechanisms pro-
moting macrophage polarization in EAT in CAD patients. In
the present study our aim was to investigate in CAD and
non-CAD patients the association between EAT adipocyte
size, macrophage inltration/polarization and TLR-2 and
TLR-4 expression.
Methods
Study population
Fifty male patients (30 CAD, undergoing coronary artery
bypass grafting surgery, and 20 non-CAD, referring to
hospital for valvular replacement surgery), aged 18e65
years, were enrolled at I.R.C.C.S. Policlinico San Donato.
Exclusion criteria were: impaired left ventricular ejection
fraction, congestive heart failure, acute myocardial infarc-
tion (<6 month), presence of pace-maker, type-1 diabetes
mellitus, neoplasm, prior major abdominal surgery, renal/
liver diseases and unstable (>5% change) body weight in
the least 6 months. CAD and non-CAD patients had similar
body mass index (BMI, kg/m
2
) (26.52 2.59 vs.
27. 11 4.17) and AST (U/L) (31.36 31 .12 vs.
30.44 42.50). ALT (U/L) (38.30 31.42 vs. 17.33 7.39),
LDL-cholesterol (mg/dL) (85.00 33.54 vs. 110.82 37.05)
and triglycerides (mg/dL) (130.10 64.80 vs.
139.80 71.27) were increased in CAD patients (p < 0.05).
HDL cholesterol was reduced (36.51 10.41 vs.
48.00 11.13; p < 0.05). The study protocol was approved
by the local Ethics Committee (ASL Milano Due, protocol
number 2516) and patients gave their written informed
consent, conducted in accordance with the Declaration of
Helsinki, as revised in 2013.
EAT and blood collection
EAT biopsy samples were harvested adjacent to the prox-
imal right coronary artery prior to initiation of cardiopul-
monary bypass pumping. For gene expression analysis,
samples were stored in Allprotect Tissue Reagent (Qiagen,
Hilden, Germany). For histological assays, tissues were
xed in 4% paraformaldehyde. EDTA plasma samples were
collected and stored at 20
C until analysis.
Adipocyte size quantication
Three mm
3
EAT biopsies were xed in 4% para-
formaldehyde for 16 h at 4
C, dehydrated in graded scale
of ethanols and parafn embedded. Sections of 4 mm were
obtained using rotary microtome (RM2245, Leica Micro-
systems GmbH, Wetzlar, Germany) and stained with
hematoxylin-eosin (SigmaeAldrich, Milan, Italy). The
adipocyte size was evaluated on 10 images acquired
using Nikon Eclipse 80i microscope equipped with digital
camera Nikon DS-5Mc (Nikon, Tokyo, Japan) and image
acquisition software (ACT-2U). Diameter and area of adi-
pocytes were measured using image processing software
(Image Pro Plus version 4.5.019; USA Media Cybernetics
Inc; Maryland, USA).
Immunohistochemical staining
Deparafnized EAT sections were rehydrated and antigen
retrieval was performed by autoclaving in sodium citrate
buffer (0.01 M, pH 6) for 5 min at 120
C. After quenching
of endogenous peroxidases (0.3% H
2
O
2
for 20 min), and
blocking with swine serum (Dako Cytomation), sections
were incubated with anti-human primary anti-
bodies:mouse monoclonal CD68 (1:100, 1 h) (Biocare
Medical, Concord, CA), mouse monoclonal CD11c (1:200,
over night, (on)) (Proteintech, Manchester, UK), mouse
monoclonal CD206 (1:20, on) (R&D Systems, Minneapolis,
MN, USA), rabbit polyclonal PLIN1 (1:200, on) (LifeSpan
Bioscience, Albuquerque, NM, USA), polyclonal rabbit TLR-
2 (1:400, Bio-Rad, Milan, Italy) and polyclonal rabbit TLR-4
(1:20,0 LifeSpan BioSciences). Amplication of immune
signal was performed using anti-mouse and anti-rabbit
HRP-polymer complex (MACH 1 Universal HRP-Polymer
detection, Biocare Medical). Betazoid DAB (Biocare
2 E. Vianello et al.
Please cite this article in press as: Vianello E, et al., Epicardial adipocyte hypertrophy: Association with M1-polarization and toll-like
receptor pathways in coronary artery disease patients, Nutrition, Metabolism & Cardiovascular Diseases (2016), http://dx.doi.org/
10.1016/j.numecd.2015.12.005
Medical) was used for color development. Sections were
counterstained with Mayers hematoxylin and mounted
with Mowiol 4e88 (Calbiochem, La Jolla, CA, USA). Nega-
tive controls were performed by replacing primary anti-
bodies with PBS. Immunohistochemical reactions were
observed and acquired with Nikon Eclipse 80i microscope.
For the semi-quantitative evaluation of IHC staining of
CD68, CD11c, CD206, TLR-2 and TLR-4, slides were
reviewed and scored by a double-blind analysis performed
by two independent scientists. We adopted the German
semi-quantitative scoring system, slightly modied for our
purpose, in considering the staining intensity and area
extent, which has been largely accepted and used in pre-
vious studies [22]. The intensity of the staining was
quantied using the following scores: 0 Z negative,
1 Z weakly positive, 2 Z moderately positive,
3 Z strongly positive. The extent of the staining was
quantied by evaluating the percentage of the positive
staining areas in relation to the whole areas of the section,
where a score of 0 was given for 0e1% reactivity, 1 point
was assigned for 1e10% reactivity, 2 points were assigned
for 11e25% reactivity, 3 points were given for 26e50%
reactivity, 4 points were given for 51e80% reactivity, and
samples with >80% reactivity were assigned a total of 5
points. Since macrophages are localized in the spaces be-
tween adipocytes, we could just evaluate a maximum of 3
points for the extent of the staining. The nal immuno-
reactive score was determined by multiplying the intensity
score by the extent score with the minimum score
attainable being 0 and a maximum score of 9. The 9-tier
scoring was also simplied by combining scores 8e9:
strong expression (þþþ), 6e7: intermediate expression
(þþ), 2e5: weak expression (þ), and 0e1: negative NRIP
expression ().
Double-immunouorescence staining
Deparafnized and rehydrated sections were blocked with
swine serum (Dako Cytomation, Milan, Italy) for 30 min at
room temperature (RT) and incubated on with polyclonal
rabbit TLR-4 (1:200) or with polyclonal rabbit TLR-2 anti-
bodies (1:400) and then with secondary TRITC-conjugated
donkey anti-rabbit IgG (R&D Systems) for 1 h at RT. Sec-
tions were secondly incubated with monoclonal mouse
CD68 (1:100, 2 h), and then with FITC-conjugated donkey
anti-mouse IgG (1:20 0, R&D Systems, 1 h). After 5 min of
DAPI incubation (AbDSerotec, Puchheim, Germany), sec-
tions were mounted with Mowiol 4-88. Negative controls
were performed by replacing primary antibodies with PBS.
Images were acquired with uorescence microscope
(Nikon Eclipse 80i).
RNA extraction and gene expression analysis of EAT
Total RNA was extracted from tissue with the RNeasy Lipid
Tissue Kit (Qiagen). RNA concentration was quantied by
NanoDrop 2000 (ThermoScientic, Wilmington, Germany)
and RNA integrity was assessed using the Agilent RNA
6000 Nano kit and the Agilent 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA). Gene expression analysis
was performed by one color microarray platform (Agilent).
Hybridization was performed using Agilent Gene Expres-
sion hybridization Kit and scanning with Agilent G2565CA
Microarray Scanner System. Data were processed using
Agilent Feature Extraction Software (10.7) with the single
color gene expression protocol and raw data were
analyzed with ChipInspector Software (Genomatix,
Munich, Germany).
Statistical analysis
Data were expressed as mean standard deviation (SD)
and analyzed by GraphPad Prism 5.0 program (GraphPad
Software, Inc., San Diego, CA). The normality of data dis-
tribution was assessed by the KolmogroveSmirnoff test.
Comparison between groups was performed using Stu-
dents two-tailed unpaired T-test or ManneWhitney U-
test, as appropriate. A p value < 0.05 was considered sta-
tistically signicant.
Results
EAT adipocytes are hypertrophic in CAD
Morphometric analysis of EAT adipocytes suggested that
CAD patients (Fig. 1a) have bigger adipocytes than non-
CAD (Fig. 1c). In CAD, EAT adipocytes displayed both
longer diameter (Fig. 1b) and larger area (Fig. 1d) than non-
CAD (diameter: 81.92 17.19 mm vs. 61.81 5.83 mm; area:
257.10 56.45 mm
2
vs. 191.40 18.82 mm
2
; p < 0.05 for
both).
Perilipin A immunoreactivity is absent in EAT from CAD
Perilipin A, a lipid droplet protein involved in lipid traf-
cking, has been used as a marker of degenerative lipid
droplets and cell death. In CAD, no perilipin A immuno-
reactivity was observed in EAT (Fig. 2a). Contrarily, a
positive immunoreactivity was observed in non-CAD
(Fig. 2b). Perilipin A mRNA was also reduced in CAD (fold
change: 1.53, p < 0.01) ( Fig. 2c).
EAT inltrating macrophages are M1-polarized in CAD
Immunohistochemical analysis revealed that CD68-
positive cells were prevalent in CAD and appear as ag-
gregates. Only scattered CD68-stained cells were present
in non-CAD (Fig. 3a and b).
Regarding macrophage polarization, CD11c-positive
cells were mostly observed in CAD (Fig. 3c and d),
whereas few CD206-positive macrophages appeared
mainly in non-CAD (Fig. 3e and f). Semi-quantitative
analysis performed with German scoring system
conrmed that, in CAD, macrophages are shifted toward
Epicardial adipocyte hypertrophy 3
Please cite this article in press as: Vianello E, et al., Epicardial adipocyte hypertrophy: Association with M1-polarization and toll-like
receptor pathways in coronary artery disease patients, Nutrition, Metabolism & Cardiovascular Diseases (2016), http://dx.doi.org/
10.1016/j.numecd.2015.12.005
Figure 1 Morphometric analysis of adipocyte sizes in CAD and non-CAD EAT samples. Hematoxylin-eosin staining of CAD (a) and non-CAD (c) EAT
sections. Bars: 60 mm. Quantication of adipocyte diameter (b) and area (d) in CAD and non-CAD patients. Shown are mean values SD. *p < 0.05.
Figure 2 Perilipin A expression in EAT. Perilipin A immunoreactivity is absent in CAD (a), whereas it is present in non-CAD (b). Bars: 10 mm.
Reduced mRNA level of perilipin A was observed in CAD (c). **p < 0.01.
4 E. Vianello et al.
Please cite this article in press as: Vianello E, et al., Epicardial adipocyte hypertrophy: Association with M1-polarization and toll-like
receptor pathways in coronary artery disease patients, Nutrition, Metabolism & Cardiovascular Diseases (2016), http://dx.doi.org/
10.1016/j.numecd.2015.12.005
an M1 pro-inammatory state (Fig. 3). At gene level we did
not nd any statistically signicant difference in CD68,
CD11c and CD206 levels between CAD and non-CAD (data
not shown).
EAT inltrating macrophages in CAD are immunoreactive
for both TLR-2 and TLR-4
IHC analysis indicated an increased immunoreactivity for
both TLR-2 and -4 in CAD (Fig. 3gel) in stromal region. Due
to their role in promoting inammatory pathways in
response to DAMPs, we then evaluated whether EAT
inltrating CD68-positive macrophages, usually localized
in these stromal regions, were immunoreactive for TLR-2
and TRL-4. In CAD, we observed that all CD68-positive
cells were also immunoreactive for both TLR-2 (Fig. 4aec)
and -4 (Fig. 4gei). In non-CAD patients, TLR-2 was almost
undetectable (Fig. 4def), whereas TLR-4 was faintly
expressed (Fig. 4len).
CAD patients displayed increased level of pro-
inammatory mediators in EAT
The pro-inammatory mediators MCP-1, TNF-a, PTX3, TLR-
2 and -4, which are involved in the innate immunity
response, as well as the anti-inammatory cytokine adi-
ponectin were evaluated in EAT. CAD patients displayed
about 2-fold increase in MCP-1 and TNF-a levels (p < 0.05),
a 1.6-fold increase in TLR-2 (p < 0.01) and 1.3 fold increase
in TLR-4 (p < 0.05). A 4-fold increase in PTX3 level has also
been observed (p < 0.05). Contrarily, adiponectin level was
1.7-fold decreased in CAD (p < 0.001) (Fig. 5).
Discussion
The novelty of our study is the observation that the
increased inammatory state observed in EAT in CAD
seems to be induced by hypertrophic and damaged adi-
pocytes and TLR-2 and TLR-4 up-regulation may represent
one potential molecular link between adipocyte death and
the activation of the immune response.
Previous studies suggested that the increased macro-
phage inltration in obese visceral as well as subcutane-
ous adipose tissue may be promoted by stressed and/or
dying adipocytes which release different cellular compo-
nents, such as residual lipid droplets. Moreover, it has
been found an association between macrophage inltra-
tion and increased adipocyte dimension [13]. To our
knowledge, our study is the rst one exploring such
relationship in EAT in CAD. We observed that in CAD, EAT
adipocytes are hypertrophic compared to non-CAD and
the loss of perilipin A immunoreactivity should suggest
the lipid droplet degeneration. Perilipin A is a lipid-
droplet associated protein involved in the regulation of
adipocyte lipolysis [23]. Previous data indicated that the
deletion of perilipin A results in leanness and reverses
obesity in db/db mouse [24]. According to these data and
our morphometric results, we expected to observe an
increased perilipin A expression in CAD patients, as a
Figure 3 Immunohistochemical and semi-quantitative analysis of
macrophage phenotype and TLR-2 and TLR-4 expression in EAT. Panels
a and b show CD68-positive cells, c and d CD11c-positive cells, e and f
CD206 positive cells. C, d, e and f inserts are enlargements of macro-
phage staining. Panels g and h show TLR-2 positive cells; i and l show
TLR-4 positive cells. Bars: aee, 30 mm; fel, 60 mm; inserts: a, 10 mm; c, d,
e and f, 5 mm (a). The table shows the semi-quantitative analysis per-
formed by German scoring of antigen presented in the gures. CD6 8,
CD11c, TLR-2 and TLR-4 were most expressed in CAD (9-tier scoring for
all antigens) than non-CAD patients. Contrarily, CD206 was lower in
CAD than non-CAD (3-tier vs. 6-tier).
Epicardial adipocyte hypertrophy 5
Please cite this article in press as: Vianello E, et al., Epicardial adipocyte hypertrophy: Association with M1-polarization and toll-like
receptor pathways in coronary artery disease patients, Nutrition, Metabolism & Cardiovascular Diseases (2016), http://dx.doi.org/
10.1016/j.numecd.2015.12.005
potential mechanism promoting adipocyte hypertrophy.
On the contrary, we observed an overall reduction in its
level. In addition to its role in the regulation of lipolysis,
the protein has also been acknowledged as a marker of
lipid droplet integrity and its down expression/depletion
is a sign of lipid droplet degeneration [13]. One potential
explanation of EAT adipocyte death in CAD may be their
increased size. In fact, it is known that adipocyte hyper-
trophy associated to deregulated cellular metabolism
might promote adipocyte death [7,25]. Moreover, the
hypertrophic state observed may be a peculiarity of CAD
pathology regardless of the anthropometric characteris-
tics of the patients. In fact, our study showed that EAT
adipocytes resulted bigger in CAD than non-CAD despite
the two groups were matched for BMI. Thus, the yet
known inammatory state previously described in EAT in
CAD could be explained by our observation of a link
between EAT hypertrophy and adipocyte death and the
presence of macrophages polarizated toward a pro-
inammatory M1 state.
The novelty of our study is also the observation that
macrophages inltrating EAT express both TLR-2 and -4
which are the main players in the innate immune
response. In fact, the activation of these receptors by
endogenous products released by perilipin A-negative
adipocytes may lead to NF-kB translocation [26] and up-
regulation of pro-inammatory mediators [26,27].
Since EAT and pericoronary fat amount have been
related to the presence and extent of coronary artery
plaques, coronary artery calcication and production of
inammatory mediators [28e30], future correlations be-
tween EAT adipocyte size, CAD severity and inammation
represent an interesting point to be addressed in future
studies.
Figure 4 Double immunouorescence staining of CD68-positive cells with anti-TLR-2 and -4 antibodies. Panels a, d, g and l show CD68 staining.
Panels b and e represent TLR-2 and panels h and m TLR-4 staining. Panels c, f, i and n represent double staining showing the colocalization of CD68
with TLRs. Bar: 10 mm.
6 E. Vianello et al.
Please cite this article in press as: Vianello E, et al., Epicardial adipocyte hypertrophy: Association with M1-polarization and toll-like
receptor pathways in coronary artery disease patients, Nutrition, Metabolism & Cardiovascular Diseases (2016), http://dx.doi.org/
10.1016/j.numecd.2015.12.005
In conclusion, our ndings suggested that EAT hyper-
trophy in CAD promotes adipocyte degeneration and
drives local inammation through increased inltration of
macrophages which are mainly polarized towards an M1
state and express both TLR-2 and TLR-4.
Acknowledgements
The authors thank: Dr. L. Menicanti, I.R.C.C.S. Policlinico
San Donato, for patient enrollment and EAT isolation; Dr. T.
Konovalova University of Regensburg, for bioinformatic
support; Ms. Judy Bagott for editing the manuscript. This
work was supported by funds from the Italian Ministry for
Health Ricerca Corrente IRCCS Policlinico San Donato
(number: 9.11.1) and internal funds from Eu Framework 7
project Lipidomic Net (number 202272) of University of
Regensburg.
Appendix A. Supplementary material
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.numecd.2015.12.005.
References
[1] Iacobellis G, Malavazos AE, Corsi MM. Epicardial fat: from the
biomolecular aspects to the clinical practice. Int J Biochem Cell Biol
2011;43:1651e4.
[2] Dozio E, Dogliotti G, Malavazos AE, Bandera F, Cassetti G,
Vianello E, et al. IL-18 level in patients undergoing coronary artery
bypass grafting surgery or valve replacement: which link with
epicardial fat depot? Int J Immunopathol Pharmacol 2012;25:
101 1e20.
[3] Dozio E, Malavazos AE, Vianello E, Briganti S, Dogliotti G,
Bandera F, et al. Interleukin-15 and soluble interleukin-15 receptor
alpha in coronary artery disease patients: association with
epicardial fat and indices of adipose tissue distribution. PLoS ONE
2014;9:e90960.
[4] Dozio E, Vianello E, Briganti S, Fink B, Malavazos AE,
Scognamiglio ET, et al. Increased reactive oxygen species produc-
tion in epicardial adipose tissues from coronary artery disease
patients is associated with brown-to-white adipocyte trans-dif-
ferentiation. Int J Cardiol 2014;174:413e4.
[5] Malavazos AE, Corsi MM, Ermetici F, Coman C, Sardanelli F, Rossi A,
et al. Proinammatory cytokines and cardiac abnormalities in
uncomplicated obesity: relationship with abdominal fat deposi-
tion. Nutr Metab Cardiovasc Dis 2007;17:294e302.
[6] Seneviratne AN, Sivagurunathan B, Monaco C. Toll-like receptors
and macrophage activation in atherosclerosis. Clin Chim Acta
2012;413:3e14.
[7] Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL,
Ferrante Jr AW. Obesity is associated with macrophage accumu-
lation in adipose tissue. J Clin Invest 2003;112:1796e808.
[8] Grotenhuis N, Vd Toom HF, Kops N, Bayon Y, Deerenberg EB,
Mulder IM, et al. In vitro model to study the biomaterial-
dependent reaction of macrophages in an inammatory environ-
ment. Br J Surg 2014;101:983e92.
[9] Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C, et al.
Coronary atherosclerosis is associated with macrophage polariza-
tion in epicardial adipose tissue. J Am Coll Cardiol 2011;58:248e55.
[10] Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S,
Maumus M, Sengenes C, et al. Remodeling phenotype of human
subcutaneous adipose tissue macrophages. Circulation 20 08;117:
806e15.
[11] Nagai Y, Watanabe Y, Takatsu K. The TLR family protein RP105/MD-
1 complex: a new player in obesity and adipose tissue inam-
mation. Adipocyte 2013;2:61e6.
[12] Vieira-Potter VJ. Inammation and macrophage modulation in
adipose tissues. Cell Microbiol 2014;16:1484e92.
[13] Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al.
Adipocyte death denes macrophage localization and function in
adipose tissue of obese mice and humans. J Lipid Res 2005;46:
2347e55.
[14] Blich M, Golan A, Arvatz G, Sebbag A, Shafat I, Sabo E, et al.
Macrophage activation by heparanase is mediated by TLR-2 and
TLR-4 and associates with plaque progression. Arterioscler
Thromb Vasc Biol 2013;33:e56e
65.
[15] Falck-Hansen M, Kassiteridi C, Monaco C. Toll-like receptors in
atherosclerosis. Int J Mol Sci 2013;14:14008e23.
[16] Piccinini AM, Midwood KS. DAMPening inammation by modu-
lating TLR signalling. Mediat Inamm 2010:2010.
[17] Karastergiou K, Evans I, Ogston N, Miheisi N, Nair D, Kaski JC, et al.
Epicardial adipokines in obesity and coronary artery disease
Figure 5 EAT expression of inammation-related molecules in CAD and non-CAD. Gene expression analysis of mediators involved in inammation
in EAT was performed with Agilent system. Shown are mean values SD. *p < 0.05, **p < 0.01 and ***p < 0.001.
Epicardial adipocyte hypertrophy 7
Please cite this article in press as: Vianello E, et al., Epicardial adipocyte hypertrophy: Association with M1-polarization and toll-like
receptor pathways in coronary artery disease patients, Nutrition, Metabolism & Cardiovascular Diseases (2016), http://dx.doi.org/
10.1016/j.numecd.2015.12.005
induce atherogenic changes in monocytes and endothelial cells.
Arterioscler Thromb Vasc Biol 2010;30:1340e6.
[18] Kortelainen ML, Porvari K. Adventitial macrophage and lympho-
cyte accumulation accompanying early stages of human coronary
atherogenesis. Cardiovasc Pathol 2014;23:193e7.
[19] Bjorkbacka H. Is toll-like receptor responsiveness a marker and
predictor of coronary artery disease? Atherosclerosis 2014;232:
197e 8.
[20] Erridge C, Samani NJ. Saturated fatty acids do not directly stimu-
late toll-like receptor signaling. Arterioscler Thromb Vasc Biol
2009;29:1944e9.
[21] Tapp LD, Shantsila E, Wrigley BJ, Montoro-Garcia S, Lip GY. TLR4
expression on monocyte subsets in myocardial infarction. J Intern
Med 2014;273:294e305.
[22] Koo CL, Kok LF, Lee MY, Wu TS, Cheng YW, Hsu JD, et al. Scoring
mechanisms of p16INK4a immunohistochemistry based on either
independent nucleic stain or mixed cytoplasmic with nucleic
expression can signicantly signal to distinguish between endo-
cervical and endometrial adenocarcinomas in a tissue microarray
study. J Transl Med 2009;7:25.
[23] Souza SC, de Vargas LM, Yamamoto MT, Lien P, Franciosa MD,
Moss LG, et al. Overexpression of perilipin A and B blocks the
ability of tumor necrosis factor alpha to increase lipolysis in 3T3-
L1 adipocytes. J Biol Chem 1998;273:24665e9.
[24] Martinez-Botas J, Anderson JB, Tessier D, Lapillonne A, Chang BH,
Quast MJ, et al. Absence of perilipin results in leanness and re-
verses obesity in Lepr(db/db) mice. Nat Genet 2000;26:474e9.
[25] Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, et al.
Endoplasmic reticulum stress links obesity, insulin action, and
type 2 diabetes. Science 2004;306 :457e61.
[26] Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a
dynamic balance. Nat Rev Immunol 2013;13:709e21.
[27] Fusaru AM, Stanciulescu CE, Surlin V, Taisescu C, Bold A, Pop OT,
et al. Role of innate immune receptors TLR2 and TLR4 as mediators
of the inammatory reaction in human visceral adipose tissue.
Rom J Morphol Embryol 2012;53:693e701.
[28] Gauss S, Klinghammer L, Steinhoff A, Raaz-Schrauder D,
Marwan M, Achenbach S, et al. Association of systemic inam-
mation with epicardial fat and coronary artery calcication.
Inamm Res 2015;64:313e9.
[29] Iacobellis G. Local and systemic effects of the multifaceted
epicardial adipose tissue depot. Nat Rev Endocrinol 2015;11:
363e71.
[30] Maurovich-Horvat P, Kallianos K, Engel LC, Szymonifka J,
Schlett CL, Koenig W, et al. Relationship of thoracic fat depots with
coronary atherosclerosis and circulating inammatory bio-
markers. Obesity (Silver Spring) 2015;23:1178e84.
8 E. Vianello et al.
Please cite this article in press as: Vianello E, et al., Epicardial adipocyte hypertrophy: Association with M1-polarization and toll-like
receptor pathways in coronary artery disease patients, Nutrition, Metabolism & Cardiovascular Diseases (2016), http://dx.doi.org/
10.1016/j.numecd.2015.12.005
... The connection between EAT and neighboring structures is mediated through the release of lipid species, cytokines, adipokines, and chemokines from adipocytes or infiltrated macrophages. In CAD patients, EAT has been described to show higher sized adipocytes and increased macrophage infiltration [3,4] and to strongly induce the release of inflammatory molecules [5][6][7][8][9], thereby contributing to the development of coronary disease and myocardial dysfunction [10,11]. In diabetic patients, the presence of CV disease has been associated with increased thickness and volume of EAT [12]. ...
... In diabetic patients, the presence of CV disease has been associated with increased thickness and volume of EAT [12]. EAT from these patients shares some alterations with those ascribed to CAD patients [3,4]. In this context, it is important to distinguish whether the features are due to diabetes itself or to the co-existence of CAD. ...
... This was reflected in the high expression of inflammatory molecules. Such increased expression was especially enhanced in the coronary samples, which concurs with previous studies [3,4], contributing then to an inflammatory state of EAT. Since the number of infiltrated macrophages was similar in the DM and DM-C samples, the higher expression of cytokines in the latter could indicate the increased inflammatory potential of these macrophages. ...
Article
Full-text available
Diabetic patients present increased volume and functional alterations in epicardial adipose tissue (EAT). We aimed to analyze EAT from type 2 diabetic patients and the inflammatory and cytotoxic effects induced on cardiomyocytes. Furthermore, we analyzed the cardioprotective role of apolipoprotein J (apoJ). EAT explants were obtained from nondiabetic patients (ND), diabetic patients without coronary disease (DM), and DM patients with coronary disease (DM-C) after heart surgery. Morphological characteristics and gene expression were evaluated. Explants were cultured for 24 h and the content of nonesterified fatty acids (NEFA) and sphingolipid species in secretomes was evaluated by lipidomic analysis. Afterwards, secretomes were added to AC16 human cardiomyocytes for 24 h in the presence or absence of cardioprotective molecules (apoJ and HDL). Cytokine release and apoptosis/necrosis were assessed by ELISA and flow cytometry. The EAT from the diabetic samples showed altered expression of genes related to lipid accumulation, insulin resistance, and inflammation. The secretomes from the DM samples presented an increased ratio of pro/anti-atherogenic ceramide (Cer) species, while those from DM-C contained the highest concentration of saturated NEFA. DM and DM-C secretomes promoted inflammation and cytotoxicity on AC16 cardiomyocytes. Exogenous Cer16:0, Cer24:1, and palmitic acid reproduced deleterious effects in AC16 cells. These effects were attenuated by exogenous apoJ. Diabetic secretomes promoted inflammation and cytotoxicity in cardiomyocytes. This effect was exacerbated in the secretomes of the DM-C samples. The increased content of specific NEFA and ceramide species seems to play a key role in inducing such deleterious effects, which are attenuated by apoJ.
... EATat may be more sensitive than EAT volume in obstructive CAD and high-risk plaque feature prediction in patients with atypical chest pain [11]. Increased EATat could be a result of inflammatory cell infiltration, such as M1-polarized macrophages, which increase inflammation [12]. Hence, quantification of EAT inflammation by assessing EATat may be a tool to monitor vascular inflammation and is also appropriate for patients [11][12][13][14][15]. ...
... Increased EATat could be a result of inflammatory cell infiltration, such as M1-polarized macrophages, which increase inflammation [12]. Hence, quantification of EAT inflammation by assessing EATat may be a tool to monitor vascular inflammation and is also appropriate for patients [11][12][13][14][15]. ...
... Given the different embryological origins (EAT from the splanchnopleuric mesoderm and ParaAT from the primitive thoracic mesenchyme) and different arterial supplies (EAT from the coronary artery and ParaAT from the internal mammary artery) [34], it is reasonable to suspect that EAT and ParaAt may have distinct biochemical properties. Some studies have shown that only epicardial fat, not paracardial fat, could serve as a predictor of cardiovascular disease [11][12][13][14]. The findings of this study are in agreement. ...
Article
Full-text available
Introduction: Denosumab preceding elective surgery is an alternative option when parathyroidectomy is not immediately possible. Denosumab (an osteoprotegerin mimic) may play a role in the cardiovascular system, which is reflected in the features of epicardial adipose tissue (EAT) and coronary artery calcification (CAC). Methods: We investigated the effects of denosumab on EAT attenuation (EATAT) and CAC in dialysis patients with secondary hyperparathyroidism (SHPT). This cohort study included patients on dialysis with SHPT. The baseline characteristics of dialysis patients and propensity score–matched non-dialysis patients were compared. Computed tomography scans of the dialysis patients (dialysis group with denosumab, n = 24; dialysis group without denosumab, n = 21) were obtained at baseline and at 6 months follow-up. Results: At baseline, the dialysis group patients had a higher EATAT-median (-71.00H ± 10.38 vs. -81.60H ± 6.03; P < 0.001) and CAC (1223A [248.50–3315] vs. 7A [0–182.5]; P < 0.001) than the non-dialysis group. At follow-up, the dialysis group without denosumab showed an increase in Agatston score (1319.50A (238.00–2587.50) to 1552.00A (335.50–2952.50); P = 0.001) without changes in EATAT-median (-71.33H ± 11.72 to -70.86H ± 12.67; P = 0.15). The dialysis group with denosumab showed no change in Agatston score (1132.2A (252.25–3260.5) to 1199.50A (324.25–2995); P = 0.19), but a significant decrease of EATAT-median (-70.71H ± 9.30 to -74.33H ± 10.28; P = 0.01). Conclusions: Denosumab may reverse EATat and retard CAC progression in dialysis patients with SHPT.
... В силу изменения клеточной биохимии важная роль в патогенезе всех этих нарушений может принадлежать гипертрофии адипоцитов ЭЖТ, степень которой более значительна у пациентов с коронарным атеросклерозом в сравнении с лицами без этой патологии [7]. Тем не менее, литературные сведения о факторах, реализующих атерогенные эффекты гипертрофированных адипоцитов ЭЖТ в клинических условиях, весьма ограничены. ...
... Хотя в ряде исследований продемонстрирована тесная взаимосвязь между гипертрофией адипоцитов и воспалением жировой ткани различной локализации, которые нельзя объяснить лишь наличием ожирения или избыточной массы тела [12], cведения о потенциальной ассоциации размера адипоцита ЭЖТ и степени его гипертрофии с процессами хронического воспаления у пациентов с коронарным атеросклерозом ограничены единичными публикациями [7]. До настоящего времени в литературе отсутствуют данные о факторах, определяющих выраженную степень гипертрофии адипоцита ЭЖТ у пациентов с коронарным атеросклерозом. ...
... Вместе с тем имеются данные о том, что в сравнении с жировыми клетками других локализаций эпикардиальные адипоциты обладают более высокой способностью к липогенезу и липолизу, а также демонстрируют повышенную экспрессию генов, связанных с провоспалительными цитокинами [19]. У пациентов с коронарным атеросклерозом обнаружено уникальное изменение транскриптома ЭЖТ, проявляющееся дифференциальной экспрессией провоспалительных и апоптотических генов и увеличением размера эпикардиальных адипоцитов [20], что подтверждают и другие авторы [7]. Вклад метавоспаления в развитие дисфункции ЭЖТ требует дальнейшего более глубокого изучения и будет являться предметом наших дальнейших исследований. ...
Article
Full-text available
The changes of epicardial adipose tissue’s (EAT) morphofunctional characteristics represent an important factor of cardiometabolic impairments development. However, factor data determining the severity of EAT adipocytes’ hypertrophy in patients with coronary atherosclerosis are absent in literature. Aim : To compare the size of the EAT adipocyte and the percentage of hypertrophied adipocytes with the parameters of glucose/insulin metabolism, blood lipid transport function, adipokines’ profile and serum levels of high sensitive C-reactive protein (hsCRP) in patients with chronic coronary artery disease (CAD) undergoing coronary artery bypass grafting (CABG); to establish statistically significant determinants of a pronou ced degree of EAT adipocytes’ hypertrophy. Material and Methods . The study included 42 patients (m/f 28/14) aged 53–72 y.o. with CAD, who underwent CABG. The material for the study was EAT adipocytes obtained by the enzymatic method from intraoperative explants. The basal blood levels of glycemia, insulinemia, C-peptide, blood lipid transport function, adipokines and hsCRP were determined. The median indicators of the size of EAT adipocytes and the proportion of EAT adipocytes over 100 μm were 87.32 μm and 14.64%, respectively. The total sample of patients was divided into two groups: gr. 1 with an average size of EAT adipocytes less than or equal to 87.32 μm and gr. 2 with an average size of EAT adipocytes more than 87.32 μm. Gr. 2 had higher body mass index, waist and hip circumferences, triglycerides, hsCRP, and lower adiponectin levels, while the median proportion of hypertrophied adipocytes was three times higher than in group 1. A model of multiple logistic regression was constructed, according to which statistically significant determinants of the pronounced EAT adipocytes’ hypertrophy are represented by the decreased level of adiponectin, and increased concentrations of hsCRP and C-peptide, which reflects the biosynthesis and secretion of insulin. The predictive accuracy of the model was 82%, sensitivity 85%, specificity 79%, AUC = 0.89. Conclusion . Our results indicate a close correlation between the development of EAT adipocytes hypertrophy, impaired production of adiponectin, insulin, and inflammation processes. Concentrations of adiponectin, hsCRP, and basal C-peptide in the blood are biomarkers that accurately determine the presence of EAT adipocyte hypertrophy.
... 33 The cellular population of EAT is rich in M1 macrophages and mast cells that infiltrate the coronary artery adventitia. 31,34 The dysfunction of EAT in obesity could be also related to an eventual onset of insulin resistance and excessive influx of FFA. Generally, insulin resistance increases with body fat, particularly in the visceral compartment. ...
Article
Full-text available
Epicardial adipose tissue (EAT) is a fat depot located between the myocardium and the visceral layer of the epicardium, which, owing to its location, can influence surrounding tissues and can act as a local transducer of systemic inflammation. The mechanisms upon which such influence depends on are however unclear. Given the role EAT undoubtedly has in the scheme of cardiovascular diseases (CVDs), understanding the impact of its cellular components is of upmost importance. Extracellular vesicles (EVs) constitute promising candidates to fill the gap in the knowledge concerning the unexplored mechanisms through which EAT promotes onset and progression of CVDs. Owing to their ability of transporting active biomolecules, EAT-derived EVs have been reported to be actively involved in the pathogenesis of ischemia/reperfusion injury, coronary atherosclerosis, heart failure, and atrial fibrillation. Exploring the precise functions EVs exert in this context may aid in connecting the dots between EAT and CVDs.
... On the other hand, this increase was suppressed by PSTE administration, which is consistent with MCP-1, M-CSF, and VEGF mRNA expression. CD11c is a transmembrane protein in large amounts in immune cells [46]. When RAW 264.7 cells had been co-cultured with 4T1 cells, the mRNA expression of CD11c and NOS, the markers of M1-macrophage, in RAW 264.7 cells decreased significantly compared to the case where it was cultured alone. ...
Article
Full-text available
Background/objectives: As peanuts germinate, the content of the components beneficial to health, such as resveratrol, increases within the peanut sprout. This study examined whether the ethanol extract of peanut sprout tea (PSTE) inhibits breast cancer growth and metastasis. Materials/methods: After orthotopically injecting 4T1 cells into BALB/c mice to induce breast cancer, 0, 30, or 60 mg/kg body weight/day of PSTE was administered orally. Angiogenesis-related protein expression in the tumors and the degree of metastasis were analyzed. 4T1 and RAW 264.7 cells were co-cultured, and reverse transcription polymerase chain reaction was performed to measure the crosstalk between breast cancer cells and macrophages. Results: PSTE reduced tumor growth and lung metastasis. In particular, PSTE decreased matrix metalloproteinase-9, platelet endothelial cell adhesion molecule-1, vascular endothelial growth factor-A, F4/80, CD11c, macrophage mannose receptor, macrophage colony-stimulating factor, and monocyte chemoattractant protein 1 expression in the tumors. Moreover, PSTE prevented 4T1 cell migration, invasion, and macrophage activity in RAW 264.7 cells. PSTE inhibited the crosstalk between 4T1 cells and RAW 264.7 cells and promoted the macrophage M1 subtype while inhibiting the M2 subtype. Conclusions: These results suggest that PSTE blocks breast cancer growth and metastasis to the lungs. This may be because the PSTE treatment inhibits the crosstalk between mammary cancer cells and macrophages and inhibits the differentiation of macrophages into the M2 subtype.
... pathway is involved in the phosphorylation of key enzymes, growth, and nuclear factors, MAPK is the family of serine/threonine protein kinases involved in several intracellular functions including cell movement, proliferation, and apoptosis [90,91]. Studies demonstrated that in coronary artery disease, the level of toll-like receptor 4(TLR4) and MI macrophages are upregulated in endothelial adipose tissue (EAT), showing that EAT is at low-grade inflammation [92]. TNF receptor-associated factor 6 (TRAF6) plays an essential role in TLR signaling, activation of nuclear factor kappa-beta (NF-kβ), and mitogen-activated protein kinase(MAPK) cell signaling pathway [93]. ...
Article
Full-text available
MicroRNAs (miRNAs) are small endogenous non-coding RNA, size range from 17 to 25 nucleotides that regulate gene expression at the post-transcriptional level. More than 2000 different types of miRNAs have been identified in humans which regulate about 60% of gene expression, since the discovery of the first miRNA in 1993. MicroRNA performs many functions such as being involved in the regulation of various biological pathways for example cell migration, cell proliferation, cell differentiation, disease progression, and initiation. miRNAs also play an important role in the development of atherosclerosis lesions, cardiac fibroblast, cardiac hypertrophy, cancer, and neurological disorders. Abnormal activation of many cell signaling pathways has been observed in the development of coronary artery disease. Abnormal expression of these candidate miRNA genes leads to up or downregulation of specific genes, these specific genes play an important role in the regulation of cell signaling pathways involved in coronary artery disease. Many studies have found that miRNAs play a key role in the regulation of crucial signaling pathways that are involved in the pathophysiology of coronary artery disease. This review is designed to investigate the role of cell signaling pathways regulated by candidate miRNAs in Coronary artery disease.
... Chronic low-grade inflammation represents one of the main driving forces leading to the malfunctioning of adipose tissue [4] and is regarded as a pathophysiological link between dysfunctional EAT and emergence of cardiovascular disorders [5,6]. The opposite is also true, as an increase in the adipocytes' number and size creates local hypoxia, followed by the release of free fatty acids and inflammatory cytokines, which ultimately leads to an accumulation of macrophages [7]. ...
Article
Full-text available
The aim of the study was to compare the morphological features of epicardial adipose tissue (EAT) adipocyte with the circulating inflammatory biomarkers and parameters of extracellular matrix remodeling in patients with coronary artery disease (CAD). We recruited 42 patients with CAD (m/f 28/14) who were scheduled for coronary artery bypass graft surgery (CABG). EAT adipocytes were obtained by the enzymatic method from intraoperative adipose tissue samples. Concentrations of secreted and lipoprotein-associated phospholipase A2 (sPLA2 and LpPLA2), TNF-α, IL-1β, IL-6, IL-10, high-sensitive C-reactive protein (hsCRP), metalloproteinase-9 (MMP-9), MMP-2, C-terminal cross-linking telopeptide of type I collagen (CTX-I), and tissue inhibitor of metalloproteinase 1 (TIMP-1) were measured in blood serum. Patients were divided into two groups: group 1—with mean EAT adipocytes’ size ≤ 87.32 μm; group 2—with mean EAT adipocytes’ size > 87.32 μm. Patients of group 2 had higher concentrations of triglycerides, hsCRP, TNF-α, and sPLA2 and a lower concentration of CTX-I. A multiple logistic regression model was created (RN2 = 0.43, p = 0.0013). Concentrations of TNF-α, sPLA2 and CTX-I appeared to be independent determinants of the EAT adipocyte hypertrophy. ROC analysis revealed the 78% accuracy, 71% sensitivity, and 85% specificity of the model, AUC = 0.82. According to our results, chronic low-grade inflammation and extracellular matrix remodeling are closely associated with the development of hypertrophy of EAT adipocytes, with serum concentrations of TNF-α, sPLA2 and CTX-I being the key predictors, describing the variability of epicardial adipocytes’ size.
Article
Full-text available
Diabetes is a long-term chronic disease, and cardiovascular disease is the leading cause of death. Diabetic cardiomyopathy (DCM), one of the cardiovascular complications of diabetes, has many uncertain factors. Epicardial fat, as the heart fat bank, functions as fatty tissue and is the heart's endocrine organ. The existence of diabetes affects the distribution of heart fat and promotes the secretion of adipokine. In different pathological conditions, it can promote the secretion of pro-inflammatory adipokine, reactive oxygen species, oxidative stress, and even autophagy, thus affecting cardiac function. In this paper, we will elaborate on the mechanism of epicardial fat in the pathogenesis of diabetic cardiomyopathy.
Article
Aims: Myeloid-derived suppressor cells (MDSCs) are major components of the tumor microenvironment and systemically accumulate in tumor-bearing hosts and patients with cancer, facilitating cancer progression. Maitake macromolecular α-glucan YM-2A, isolated from Grifola frondosa, inhibits tumor growth by enhancing immune responses. The present study investigated the effects of YM-2A on the immunosuppressive potential of MDSCs. Main methods: YM-2A was orally administered to CT26 tumor-bearing mice, and the number of immune cells in the spleen and tumor was measured. Splenic MDSCs isolated from the CT26 tumor-bearing mice were treated with YM-2A and co-cultured with T cells to measure their inhibitory effect on T cell proliferation. For adoptive transfer of monocytic MDSCs (M-MDSCs), YM-2A-treated M-MDSCs mixed with CT26 cells were implanted subcutaneously in the mice to measure the tumor growth rate. Key findings: YM-2A selectively reduced the accumulation of M-MDSCs but not that of polymorphonuclear MDSCs (PMN-MDSCs) in CT26 tumor-bearing mice. In tumor tissues, YM-2A treatment induced the polarity of immunostimulatory M1-phenotype; furthermore, it increased the infiltration of dendritic, natural killer, and CD4+ and CD8+ T cells. YM-2A treatment of purified M-MDSCs from CT-26 tumor-bearing mice induced dectin-1-dependent differentiation into M1 macrophages. YM-2A-treated M-MDSCs lost their inhibitory activity against proliferation and activation of CD8+ T cells. Furthermore, adoptive transfer of M-MDSCs treated with YM-2A inhibited CT26 tumor growth. Significance: YM-2A promotes the differentiation of M-MDSCs into immunostimulatory M1 macrophages, thereby enhancing the efficacy of cancer immunotherapy.
Article
Background and aims This study investigates the expression of novel adipocytokines and inflammatory cells infiltration in epicardial adipose tissue (EAT) and subcutaneous adipose tissue (SAT) between 27 coronary artery disease (CAD) and 21 non-CAD (NCAD) patients enrolled from September 2020 to September 2021. Methods and results Serum, gene, and protein expression levels of the novel adipocytokines were determined using ELISA, RT-qPCR, and western blot analyses. The number of blood vessels and adipocytes morphology were measured via hematoxylin-eosin staining, and inflammatory cells infiltration was examined via immunohistochemistry. Serum ANGPTL8, CTRP5, and Wnt5a levels were higher in the CAD than in the NCAD group, while serum CTRP3, Sfrp5, and ZAG levels were lower in the CAD than in the NCAD group. Compared to the EAT of NCAD and SAT of CAD patients, the EAT of CAD patients had higher mRNA levels of ANGPTL8, CTRP5, and Wnt5a while lower levels of CTRP3, Sfrp5, and ZAG; higher protein expression levels of ANGPTL8 and CTRP5 but lower levels of CTRP3; more blood vessels; and higher infiltration rates of macrophages (CD68 + ), pro-inflammatory M1 macrophages (CD11c + ), mast cells (Tryptase + ), T lymphocytes (CD3 + ), and B lymphocytes (CD20 + ) but lower infiltration rates of anti-inflammatory M2 macrophages (CD206 + ). Conclusion Novel adipocytokines and inflammatory cells infiltration are dysregulated in human EAT, and could be important pathophysiological mechanisms and novelly promising medicating targets of CAD.
Article
Full-text available
The adipose tissue is an active endocrine organ that harbors not only mature and developing adipocytes but also a wide array of immune cells, including macrophages, a key immune cell in determining metabolic functionality. With adipose tissue expansion, M1 pro-inflammatory macrophage infiltration increases, activates other immune cells, and affects lipid trafficking and metabolism, in part via inhibiting mitochondrial function and increasing reactive oxygen species (ROS). The pro-inflammatory cytokines produced and released interfere with insulin signaling, while inhibiting M1 macrophage activation improves systemic insulin sensitivity. In healthy adipose tissue, M2 alternative macrophages predominate and associate with enhanced lipid handling and mitochondrial function, anti-inflammatory cytokine production, and inhibition of ROS. The sequence of events leading to macrophage infiltration and activation in adipose tissue remains incompletely understood but lipid handling of both macrophages and adipocytes appears to play a major role.
Article
White adipose tissue from different locations is characterized by significant differences in the structure of adipocyte "secretoma". Fat accumulation in the central-visceral depots is usually associated with a chronic inflammatory state, which is complicated by the metabolic syndrome. Recently, the adipose tissue was emerged to have an essential role in the innate immunity, adipocytes being considered effector cells due to the presence of the Toll-like receptors (TLRs). In this study, we compared the expression of TNF-α, TLR2 and TLR4 in peripheral-subcutaneous and central-peritoneal adipose depots in three different conditions - lean, obese and obese diabetic - using immunohistochemistry. Our results suggest a correlation between the incidence of the stromal vascular cells and adipocytes TNF-α and TLR4 in the visceral depots in strong correlation with adipose tissue expansion. TLR2 positive cells were seen in the peripheral depots from all groups without any association with fat accumulation. These results focus on the existence of a new pathogenic pathway, the activation of TLR4, for the involvement of visceral adipose tissue in the activation and maintenance of the inflammatory cascade in obesity.
Article
The aim of the study was to determine the relationship of various thoracic fat depots with the presence and extent of coronary artery plaque and circulating biomarkers. In 342 patients (52 ± 11 years, 61% male, BMI 29.1 ± 5.9 kg/m(2) ) with coronary computed tomography (CT), angiography, we measured the fat volume in four thoracic depots (pericoronary, epicardial, periaortic, extracardiac), assessed coronary plaque, and determined the circulating levels of C-reactive protein, tumor necrosis factor alpha, plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, and adiponectin. The extent of coronary plaque was classified into three groups: 0, 1-3, and >3 segments. Patients with plaque (n =169, 49%) had higher volumes of all four fat depots as compared to patients without plaque (all P < 0.01), despite similar BMI (P = 0.18). Extracardiac fat was most strongly correlated with BMI (r = 0.45, P < 0.001), while pericoronary fat was least (r = 0.21, P < 0.001). Only pericoronary fat remained associated with coronary plaque in adjusted analyses. Inflammatory biomarkers showed a positive correlation with pericoronary fat (all P < 0.0001), whereas adiponectin was not associated with this fat compartment (P = 0.60) and showed a negative correlation with all other fat depots (all P < 0.001). Pericoronary fat is independently associated with coronary artery disease (CAD). Its correlation with inflammatory biomarkers suggests that while systemic inflammation plays a role in the pathogenesis of CAD, there are additional local effects that may exist. © 2015 The Obesity Society.
Article
Epicardial adipose tissue is a unique and multifaceted fat depot with local and systemic effects. This tissue is distinguished from other visceral fat depots by a number of anatomical and metabolic features, such as increased fatty acid metabolism and a unique transcriptome enriched in genes that are associated with inflammation and endothelial function. Epicardial fat and the heart share an unobstructed microcirculation, which suggests these tissues might interact. Under normal physiological conditions, epicardial fat has metabolic, thermogenic (similar to brown fat) and mechanical (cardioprotective) characteristics. Development of pathological conditions might drive the phenotype of epicardial fat such that it becomes harmful to the myocardium and the coronary arteries. The equilibrium between protective and detrimental effects of this tissue is fragile. Expression of the epicardial-fat-specific transcriptome is downregulated in the presence of severe and advanced coronary artery disease. Improved local vascularization, weight loss and targeted medications can restore the protective physiological functions of epicardial fat. Measurements of epicardial fat have several important applications in the clinical setting: accurate measurement of its thickness or volume is correlated with visceral adiposity, coronary artery disease, the metabolic syndrome, fatty liver disease and cardiac changes. On account of this simple clinical assessment, epicardial fat is a reliable marker of cardiovascular risk and an appealing surrogate for assessing the efficacy of drugs that modulate adipose tissues.
Article
Background: Increased epicardial fat volume (EFV) has been shown to be associated with coronary atherosclerosis. While it is postulated to be an independent risk factor, a possible mechanism is local or systemic inflammation. We analyzed the relationship between coronary atherosclerosis, quantified by coronary calcium in CT, epicardial fat volume and systemic inflammation. Methods: Using non-enhanced dual-source CT, we quantified epicardial fat volume (EFV) and coronary artery calcium (CAC) in 391 patients who underwent coronary computed tomography for suspected coronary artery disease. In addition to traditional risk factors, serum markers of systemic inflammation were measured (IL-1α, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10,IL-12, IL-13, IL-15, IL-17, IFN-γ, TNF-α, hs-CRP, GM-CS, G-CSF, MCP-1, MIP-1, Eotaxin and IP-10). In 94 patients follow-up data were obtained after 1.9 ± 0.5 years. Results: The 391 patients had a mean age of 60 ± 10 years, and 69 % were males. Mean EFV was 116 ± 50 mL. Median CAC was 12 (IQR 0; 152). CAC and EFV showed a significant correlation (ρ = 0.37; P < 0.001). EFV and CAC were significantly correlated with the traditional risk factors like age, male gender, diabetes, smoking and hypertension. With regard to biomarkers, CAC was significantly associated (negatively) to G-CSF and IL-13. EFV (median binned) was significantly associated (positively) with IP-10 (P = 0.002) and MCP-1 (ρ = 0.037). In follow-up, EFV showed a mean annualized progression of 6 mL (IQR 3; 9) (P < 0.001); CAC progressed by a mean of six Agatston Units (IQR 0; 30). The progression of CAC was significantly correlated with the extent of EFV (P < 0.001) while there was no significant correlation between progression of EFV or CAC with systemic inflammation markers. Conclusion: Epicardial fat volume and the baseline extent as well as progression of coronary atherosclerosis-measured by the calcium score-are significantly correlated. While both baseline EFV and CAC displayed significant correlations with systemic inflammation markers, biomarkers were not predictive of the progression of CAC or EFV.
Article
Background: Macrophages play an important role in the reaction to biomaterials, which sometimes have to be used in a surgical field at risk of contamination. The macrophage phenotype in reaction to biomaterials in an inflammatory environment was evaluated in both an in vivo and in vitro setting. Methods: In the in vivo setting, polypropylene (PP) biomaterial was implanted for 28 days in the contaminated abdominal wall of rats, and upon removal analysed by routine histology as well as immunohistochemistry for CD68 (marker for macrophages), inducible nitric oxide synthase (iNOS - a marker for proinflammatory M1 macrophages) and CD206 (marker for anti-inflammatory M2 macrophages). For the in vitro model, human peripheral blood monocytes were cultured for 3 days on biomaterials made from PP, collagen (COL), polyethylene terephthalate (PET) and PET coated with collagen (PET+COL). These experiments were performed both with and without lipopolysaccharide and interferon γ stimulation. Secretion of both M1- and M2-related proteins was measured, and a relative M1/M2 index was calculated. Results: In vivo, iNOS- and CD206-positive cells were found around the fibres of the implanted PP biomaterial. In vitro, macrophages on both PP and COL biomaterial had a relatively low M1/M2 index. Macrophages on the PET biomaterial had a high M1/M2 index, with the highest increase of M1 cytokines in an inflammatory environment. Macrophages on the PET+COL biomaterial also had a high M1/M2 index. Conclusion: Macrophages in an inflammatory environment in vitro still react in a biomaterial-dependent manner. This model can help to select biomaterials that are tolerated best in a surgical environment at risk of contamination.